In patients with diabetic wounds, copper oxide impregnated dressings were noninferior to standard negative pressure wound therapy.

The FDA has granted clearance for the CardioTag device to assess cardiac function and improve patient outcomes across various healthcare settings.

Relatives bereaved by natural death with high and sustained grief symptoms have increased mental health care use and mortality for up to 10 years after the loss.

Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.

Researchers have found that use of retinal vascular analysis for prediction of stroke risk is superior to traditional prediction models.

Researchers determined second malignant neoplasms and cardiovascular disease present a persistent and meaningful risk for mortality among survivors of HL.

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D).

Moderate to severe OSA was associated with increased risk for severe and critical COVID-19, particularly in those with severe intermittent hypoxia.

A study has found that patients with peripheral artery disease and acute myocardial infarction have worse in-hospital outcomes.

Moderate-to-vigorous physical activity (MVPA) decreases from young adulthood into middle age, with accelerated declines seen within 2 years prior to a cardiovascular disease (CVD) event.

There are similar outcomes between patients transported by EMS and mobile stroke units, but mobile stroke units have more favorable time metrics.